Unicycive Therapeutics Inc (UNCY)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $97.25M
Last updated: Nov 17, 2026 at 11:06 AM ET
Unicycive Therapeutics Inc (UNCY) Competitors
The companies most similar to Unicycive Therapeutics are vTv Therapeutics (VTVT), Immunic (IMUX) and Vivani Medical (VANI). By market cap, Unicycive Therapeutics ranks 7th of the 13 companies on this page; Bicycle Therapeutics (BCYC) is the largest at $236.22M.
Peer Comparison
UNCY's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Unicycive Therapeutics (UNCY) | $97.25M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Immunic Inc (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vivani Medical Inc. (VANI) | $91.11M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Pmv Pharmaceuticals Inc (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Zura Bio Limited Class A Ordinary Shares (ZURA) | $119.44M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Equillium Inc (EQ) | $106.20M | N/A | 29.3x | 0.0% | N/A | -52.3% | 0.00% |
| Humacyte Inc (HUMA) | $155.12M | N/A | 62.6x | 0.0% | -60.5% | 36.5% | 0.00% |
| TuHURA Biosciences Inc (HURA) | $88.58M | N/A | N/A | 0.0% | -81.8% | 0.0% | 0.00% |
| Cognition Therapeutics Inc (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Voyager Therapeutics Inc (VYGR) | $107.66M | N/A | 4.0x | 0.0% | N/A | -70.0% | 0.00% |
| Bicycle Therapeutics Ltd (BCYC) | $236.22M | N/A | 2.7x | -169.8% | N/A | 190.2% | 0.00% |
| Peer median | $99.27M | N/A | 16.7x | 0.0% | -71.1% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Unicycive Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
| Immunic Inc (IMUX) | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune... | IMUX competitors |
| Vivani Medical Inc. (VANI) | Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery... | VANI competitors |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Pmv Pharmaceuticals Inc (PMVP) | PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53... | PMVP competitors |
| Zura Bio Limited Class A Ordinary Shares (ZURA) | Zura Bio Limited (Ticker: ZURA) is a biotechnology firm dedicated to developing breakthrough therapies for autoimmune disorders and rare diseases. | ZURA competitors |
| Equillium Inc (EQ) | Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory... | EQ competitors |
| Humacyte Inc (HUMA) | Humacyte Inc (HUMA) is a groundbreaking biotechnology firm at the forefront of vascular and regenerative medicine... | HUMA competitors |
| TuHURA Biosciences Inc (HURA) | TuHURA Biosciences Inc is a pioneering biotechnology firm committed to advancing immunotherapy solutions for cancer and autoimmune diseases. | HURA competitors |
| Cognition Therapeutics Inc (CGTX) | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting... | CGTX competitors |
| Voyager Therapeutics Inc (VYGR) | Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. | VYGR competitors |
| Bicycle Therapeutics Ltd (BCYC) | Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. | BCYC competitors |
Frequently Asked Questions About UNCY
Who are Unicycive Therapeutics' main competitors?
The companies most similar to Unicycive Therapeutics include vTv Therapeutics (VTVT), Immunic (IMUX), Vivani Medical (VANI), Tenaya Therapeutics (TNYA) and Pmv Pharmaceuticals (PMVP), listed from the closest match.
Who is Unicycive Therapeutics' biggest competitor?
Bicycle Therapeutics (BCYC) is the largest of the similar companies at $236.22M; vTv Therapeutics (VTVT) is the closest match by business profile, size, sector and industry.
How does UNCY stock compare with its competitors?
UNCY's net margin is 0.0% against a peer median of 0.0%.
Which of Unicycive Therapeutics' competitors pays a higher dividend?
Unicycive Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Unicycive Therapeutics bigger than its competitors?
No. Unicycive Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Bicycle Therapeutics (BCYC) at $236.22M.
UNCY pages: Overview, Earnings, Forecast, Financials, Competitors